These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 24626392)

  • 1. Immune suppression by neutrophils in HIV-1 infection: role of PD-L1/PD-1 pathway.
    Bowers NL; Helton ES; Huijbregts RP; Goepfert PA; Heath SL; Hel Z
    PLoS Pathog; 2014 Mar; 10(3):e1003993. PubMed ID: 24626392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frontline Science: Defects in immune function in patients with sepsis are associated with PD-1 or PD-L1 expression and can be restored by antibodies targeting PD-1 or PD-L1.
    Patera AC; Drewry AM; Chang K; Beiter ER; Osborne D; Hotchkiss RS
    J Leukoc Biol; 2016 Dec; 100(6):1239-1254. PubMed ID: 27671246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased Neutrophil Aging Contributes to T Cell Immune Suppression by PD-L1 and Arginase-1 in HIV-1 Treatment Naïve Patients.
    Liu K; Huang HH; Yang T; Jiao YM; Zhang C; Song JW; Zhang JY; Zhou CB; Yuan JH; Cao WJ; Mu XY; Zhou MJ; Li HJ; Shi M; Xu R; Wang FS
    Front Immunol; 2021; 12():670616. PubMed ID: 34489929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrasting Roles of the PD-1 Signaling Pathway in Dendritic Cell-Mediated Induction and Regulation of HIV-1-Specific Effector T Cell Functions.
    Garcia-Bates TM; Palma ML; Shen C; Gambotto A; Macatangay BJC; Ferris RL; Rinaldo CR; Mailliard RB
    J Virol; 2019 Mar; 93(5):. PubMed ID: 30541848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PD-1 and its ligand PD-L1 are progressively up-regulated on CD4 and CD8 T-cells in HIV-2 infection irrespective of the presence of viremia.
    Tendeiro R; Foxall RB; Baptista AP; Pinto F; Soares RS; Cavaleiro R; Valadas E; Gomes P; Victorino RM; Sousa AE
    AIDS; 2012 Jun; 26(9):1065-71. PubMed ID: 22441249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential impact of PD-1 and/or interleukin-10 blockade on HIV-1-specific CD4 T cell and antigen-presenting cell functions.
    Porichis F; Hart MG; Zupkosky J; Barblu L; Kwon DS; McMullen A; Brennan T; Ahmed R; Freeman GJ; Kavanagh DG; Kaufmann DE
    J Virol; 2014 Mar; 88(5):2508-18. PubMed ID: 24352453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PD-L1 engagement on T cells promotes self-tolerance and suppression of neighboring macrophages and effector T cells in cancer.
    Diskin B; Adam S; Cassini MF; Sanchez G; Liria M; Aykut B; Buttar C; Li E; Sundberg B; Salas RD; Chen R; Wang J; Kim M; Farooq MS; Nguy S; Fedele C; Tang KH; Chen T; Wang W; Hundeyin M; Rossi JAK; Kurz E; Haq MIU; Karlen J; Kruger E; Sekendiz Z; Wu D; Shadaloey SAA; Baptiste G; Werba G; Selvaraj S; Loomis C; Wong KK; Leinwand J; Miller G
    Nat Immunol; 2020 Apr; 21(4):442-454. PubMed ID: 32152508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Programmed death (PD)-1 molecule and its ligand PD-L1 distribution among memory CD4 and CD8 T cell subsets in human immunodeficiency virus-1-infected individuals.
    Rosignoli G; Lim CH; Bower M; Gotch F; Imami N
    Clin Exp Immunol; 2009 Jul; 157(1):90-7. PubMed ID: 19659774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myeloid-Derived Suppressor Cells Associated With Disease Progression in Primary HIV Infection: PD-L1 Blockade Attenuates Inhibition.
    Zhang ZN; Yi N; Zhang TW; Zhang LL; Wu X; Liu M; Fu YJ; He SJ; Jiang YJ; Ding HB; Chu ZX; Shang H
    J Acquir Immune Defic Syndr; 2017 Oct; 76(2):200-208. PubMed ID: 28570288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Programmed Cell Death Ligand (PD-L)-1 Contributes to the Regulation of CD4
    de Freitas E Silva R; Gálvez RI; Pereira VRA; de Brito MEF; Choy SL; Lotter H; Bosurgi L; Jacobs T
    Front Immunol; 2020; 11():574491. PubMed ID: 33193363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow-derived mesenchymal stem cells inhibit CD8
    Liu Z; Mi F; Han M; Tian M; Deng L; Meng N; Luo J; Fu R
    Clin Exp Immunol; 2021 Jul; 205(1):53-62. PubMed ID: 33735518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD72/CD100 and PD-1/PD-L1 markers are increased on T and B cells in HIV-1+ viremic individuals, and CD72/CD100 axis is correlated with T-cell exhaustion.
    Correa-Rocha R; Lopez-Abente J; Gutierrez C; Pérez-Fernández VA; Prieto-Sánchez A; Moreno-Guillen S; Muñoz-Fernández MÁ; Pion M
    PLoS One; 2018; 13(8):e0203419. PubMed ID: 30161254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-mediated phosphatidylinositol 3-kinase/serine-threonine kinase activation in APCs leads to programmed death-1 ligand upregulation and suppression of HIV-specific CD8 T cells.
    Muthumani K; Shedlock DJ; Choo DK; Fagone P; Kawalekar OU; Goodman J; Bian CB; Ramanathan AA; Atman P; Tebas P; Chattergoon MA; Choo AY; Weiner DB
    J Immunol; 2011 Sep; 187(6):2932-43. PubMed ID: 21856939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The PD-1/PD-L1 pathway in human pathology.
    Saresella M; Rainone V; Al-Daghri NM; Clerici M; Trabattoni D
    Curr Mol Med; 2012 Mar; 12(3):259-67. PubMed ID: 22300137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil and Granulocytic Myeloid-Derived Suppressor Cell-Mediated T Cell Suppression Significantly Contributes to Immune Dysregulation in Common Variable Immunodeficiency Disorders.
    Vlkova M; Chovancova Z; Nechvatalova J; Connelly AN; Davis MD; Slanina P; Travnickova L; Litzman M; Grymova T; Soucek P; Freiberger T; Litzman J; Hel Z
    J Immunol; 2019 Jan; 202(1):93-104. PubMed ID: 30487174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PD-1/PD-L1 blockade can enhance HIV-1 Gag-specific T cell immunity elicited by dendritic cell-directed lentiviral vaccines.
    Dai B; Xiao L; Bryson PD; Fang J; Wang P
    Mol Ther; 2012 Sep; 20(9):1800-9. PubMed ID: 22588271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nocardia Rubra Cell Wall Skeleton Up-Regulates T Cell Subsets and Inhibits PD-1/PD-L1 Pathway to Promote Local Immune Status of Patients With High-Risk Human Papillomavirus Infection and Cervical Intraepithelial Neoplasia.
    Chen W; Zhang Y; Zhao C; Shao S; Zhang Y; Li X; Bai X; Guo Q; Liu Q; Tang J; Zhang L
    Front Immunol; 2020; 11():612547. PubMed ID: 33552075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactive glia promote development of CD103
    Prasad S; Hu S; Sheng WS; Chauhan P; Lokensgard JR
    Immun Inflamm Dis; 2018 Jun; 6(2):332-344. PubMed ID: 29602245
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    da Fonseca-Martins AM; de Souza Lima-Gomes P; Antunes MM; de Moura RG; Covre LP; Calôba C; Rocha VG; Pereira RM; Menezes GB; Gomes DCO; Saraiva EM; de Matos Guedes HL
    Front Immunol; 2021; 12():598943. PubMed ID: 34211455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of PD-L1 inhibition effects for HIV-infected individuals.
    Zheltkova V; Argilaguet J; Peligero C; Bocharov G; Meyerhans A
    PLoS Comput Biol; 2019 Nov; 15(11):e1007401. PubMed ID: 31693657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.